AAAAAA

   
Results: 1-12 |
Results: 12

Authors: Hait, WN
Citation: Wn. Hait, The prognostic and predictive values of ECD-HER-2, CLIN CANC R, 7(9), 2001, pp. 2601-2604

Authors: Yang, JM Vassil, AD Hait, WN
Citation: Jm. Yang et al., Activation of phospholipase C induces the expression of the multidrug resistance (MDR1) gene through the Raf-MAPK pathway, MOLEC PHARM, 60(4), 2001, pp. 674-680

Authors: Sullivan, GF Yang, YM Vassil, A Yang, J Bash-Babula, J Hait, WN
Citation: Gf. Sullivan et al., Modulation of MDR/MRP by wild-type and mutant p53 - Sullivan et al. reply, J CLIN INV, 107(5), 2001, pp. 645-646

Authors: Yang, J Yang, JM Iannone, M Shih, WJ Lin, Y Hait, WN
Citation: J. Yang et al., Disruption of the EF-2 kinase/Hsp90 protein complex: A possible mechanism to inhibit glioblastoma by geldanamycin, CANCER RES, 61(10), 2001, pp. 4010-4016

Authors: Staal, RGW Yang, JM Hait, WN Sonsalla, RK
Citation: Rgw. Staal et al., Interactions of 1-methyl-4-phenylpyridinium and other compounds with P-glycoprotein: relevance to toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, BRAIN RES, 910(1-2), 2001, pp. 116-125

Authors: Sullivan, GF Yang, JM Vassil, A Yang, J Bash-Babula, J Hait, WN
Citation: Gf. Sullivan et al., Regulation of expression of the multidrug resistance protein MRP1 by p53 in human prostate cancer cells, J CLIN INV, 105(9), 2000, pp. 1261-1267

Authors: DiPaolo, RS Rafi, MM Vyas, V Toppmeyer, D Rubin, E Patel, J Goodin, S Medina, M Medina, P Zamek, R Zhang, C White, E Gupta, E Hait, WN
Citation: Rs. Dipaolo et al., Phase I clinical and pharmacologic study of 13-cis-retinoic acid, interferon alfa, and paclitaxel in patients with prostate cancer and other advancedmalignancies, J CL ONCOL, 17(7), 1999, pp. 2213-2218

Authors: DiPaola, RS Hait, WN Gallo, MA
Citation: Rs. Dipaola et al., PC-SPES in prostate cancer - Reply, N ENG J MED, 340(7), 1999, pp. 567-568

Authors: Zhang, CC Yang, JM Bash-Babula, J White, E Murphy, M Levine, AJ Hait, WN
Citation: Cc. Zhang et al., DNA damage increases sensitivity to Vinca alkaloids and decreases sensitivity to taxanes through p53-dependent repression of microtubule-associated protein 4, CANCER RES, 59(15), 1999, pp. 3663-3670

Authors: Parmer, TG Ward, MD Yurkow, EJ Vyas, VH Kearney, TJ Hait, WN
Citation: Tg. Parmer et al., Activity and regulation by growth factors of calmodulin dependent protein kinase III (elongation factor 2-kinase) in human breast cancer, BR J CANC, 79(1), 1999, pp. 59-64

Authors: Yang, JM Yang, GY Medina, DJ Vassil, AD Liao, J Hait, WN
Citation: Jm. Yang et al., Treatment of multidrug resistant (MDR1) murine leukemia with P-glycoprotein substrates accelerates the course of the disease, BIOC BIOP R, 266(1), 1999, pp. 167-173

Authors: Hait, WN Toppmeyer, DL DiPaola, RS
Citation: Wn. Hait et al., Medical treatment of breast cancer, BAS CLIN ON, 17, 1999, pp. 69-88
Risultati: 1-12 |